Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Nanomedicine

Silence the target

A new formulation of magnetic nanoparticles steered to cells by external magnets can deliver nucleic acids to turn off the growth of tumour blood vessels in mice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Magnetic targeting in drug and gene delivery.

C. PLANK / OZ BIOSCIENCES

References

  1. Namiki, Y. et al. Nature Nanotech. 4, 598–606 (2009).

    Article  CAS  Google Scholar 

  2. Olive, K. P. et al. Science 324, 1457–1461 (2009).

    Article  CAS  Google Scholar 

  3. Tseng, Y. C. et al. Adv. Drug Deliv. Rev. 61, 721–731 (2009).

    Article  CAS  Google Scholar 

  4. Medarova, Z. et al. Nature Med. 13, 372–377 (2007).

    Article  CAS  Google Scholar 

  5. Oh, Y. K. & Park, T. G. Adv. Drug Deliv. Rev. 61, 850–862 (2009).

    Article  CAS  Google Scholar 

  6. Alksne, J. F. et al. J. Neurosurg. 25, 516–525 (1966).

    Article  CAS  Google Scholar 

  7. Widder, K. J. et al. Proc. Soc. Exp. Biol. Med. 158, 141–146 (1978).

    Article  CAS  Google Scholar 

  8. Lubbe, A. S. et al. Cancer Res. 56, 4686–4693 (1996).

    CAS  Google Scholar 

  9. Lemke, A. J. et al. Eur. Radiol. 14, 1949–1955 (2004).

    Article  Google Scholar 

  10. Mykhaylyk, O. et al. Nature Protoc. 2, 2391–2411 (2007).

    Article  CAS  Google Scholar 

  11. Hood, J. D. et al. Science 296, 2404–2407 (2002).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author is a co-founder of the biotech company OZ Biosciences (OZB), Marseille, France. OZB develops and markets nanomagnetic reagents for nucleic acid delivery. The authors whose paper is discussed in this News & Views have used such reagents from OZB and have shown that their own reagents are superior.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plank, C. Silence the target. Nature Nanotech 4, 544–545 (2009). https://doi.org/10.1038/nnano.2009.251

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2009.251

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing